title: Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement.
abstract: METHODS
  Update of the 2009 US Preventive Services Task Force (USPSTF) recommendation on screening for depression in adults.
  
  
  METHODS
  The USPSTF reviewed the evidence on the benefits and harms of screening for depression in adult populations, including older adults and pregnant and postpartum women; the accuracy of depression screening instruments; and the benefits and harms of depression treatment in these populations.
  
  
  METHODS
  This recommendation applies to adults 18 years and older.
  
  
  CONCLUSIONS
  The USPSTF recommends screening for depression in the general adult population, including pregnant and postpartum women. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up. (B recommendation).
authors.affiliation: Mount Sinai School of Medicine, New York2James J. Peters Veterans Affairs Medical Center, Bronx, New York.
authors.forename: Albert L
authors.initials: AL
authors.lastname: Siu
authors.affiliation: University of California, San Francisco.
authors.forename: Kirsten
authors.initials: K
authors.lastname: Bibbins-Domingo
authors.affiliation: Group Health Research Institute, Seattle, Washington.
authors.forename: David C
authors.initials: DC
authors.lastname: Grossman
authors.affiliation: University of Wisconsin, Madison.
authors.forename: Linda Ciofu
authors.initials: LC
authors.lastname: Baumann
authors.affiliation: Columbia University, New York, New York.
authors.forename: Karina W
authors.initials: KW
authors.lastname: Davidson
authors.affiliation: University of Georgia, Athens.
authors.forename: Mark
authors.initials: M
authors.lastname: Ebell
authors.affiliation: Pima County Department of Health, Tucson, Arizona.
authors.forename: Francisco A R
authors.initials: FA
authors.lastname: García
authors.affiliation: Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
authors.forename: Matthew
authors.initials: M
authors.lastname: Gillman
authors.affiliation: Independent consultant, Washington, DC.
authors.forename: Jessica
authors.initials: J
authors.lastname: Herzstein
authors.affiliation: Duke University, Durham, North Carolina.
authors.forename: Alex R
authors.initials: AR
authors.lastname: Kemper
authors.affiliation: Fairfax Family Practice, Fairfax, Virginia13Virginia Commonwealth University, Richmond.
authors.forename: Alex H
authors.initials: AH
authors.lastname: Krist
authors.affiliation: New York University, New York.
authors.forename: Ann E
authors.initials: AE
authors.lastname: Kurth
authors.affiliation: Veterans Affairs Palo Alto Health Care System, Palo Alto, California16Stanford University, Stanford, California.
authors.forename: Douglas K
authors.initials: DK
authors.lastname: Owens
authors.affiliation: University of Washington, Seattle.
authors.forename: William R
authors.initials: WR
authors.lastname: Phillips
authors.affiliation: Brown University, Providence, Rhode Island.
authors.forename: Maureen G
authors.initials: MG
authors.lastname: Phipps
authors.affiliation: University of North Carolina, Chapel Hill.
authors.forename: Michael P
authors.initials: MP
authors.lastname: Pignone
mesh_terms: D000328:Adult; D026683:Advisory Committees; D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects; D003863:Depression / Q000175:diagnosis* / Q000628:therapy; D019052:Depression, Postpartum / Q000175:diagnosis* / Q000628:therapy; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D018570:Risk Assessment; D014481:United States
chemical_list: D018687:Antidepressive Agents, Second-Generation